Fresh Tracks Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FRTX research report →
Companywww.frtx.com
Fresh Tracks Therapeutics, Inc. , a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors.
- CEO
- Albert Nicholas Marchio II
- IPO
- 1993
- Employees
- 4
- HQ
- Boulder, CO, US
Price Chart
Valuation
- Market Cap
- $5.59M
- P/E
- -0.97
- P/S
- 0.70
- P/B
- 0.56
- EV/EBITDA
- 0.94
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -79.44%
- Net Margin
- -71.12%
- ROE
- -66.50%
- ROIC
- -64.05%
Growth & Income
- Revenue
- $8.01M · 15.31%
- Net Income
- $-5,694,000 · 72.44%
- EPS
- $-0.96 · 86.96%
- Op Income
- $-6,360,000
- FCF YoY
- 77.59%
Performance & Tape
- 52W High
- $1.03
- 52W Low
- $0.03
- 50D MA
- $0.81
- 200D MA
- $0.81
- Beta
- 1.17
- Avg Volume
- 2.67K
Get TickerSpark's AI analysis on FRTX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 10, 24 | Exploration Capital, LLC | buy | 86,185 |
| Jun 7, 24 | Exploration Capital, LLC | buy | 319,315 |
| May 31, 24 | Exploration Capital, LLC | buy | 516 |
| May 30, 24 | Exploration Capital, LLC | buy | 9,838 |
| May 29, 24 | Exploration Capital, LLC | buy | 80 |
| May 23, 24 | Exploration Capital, LLC | buy | 15,627 |
| May 22, 24 | Exploration Capital, LLC | buy | 383 |
| May 21, 24 | Exploration Capital, LLC | buy | 6,879 |
| May 20, 24 | Exploration Capital, LLC | buy | 797 |
| May 16, 24 | Exploration Capital, LLC | buy | 73,768 |
Our FRTX Coverage
We haven't published any research on FRTX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FRTX Report →